Vimarsana
Biggest News Aggregation in the World

Bluesphere Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bluesphere Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bluesphere Bio Today - Breaking & Trending Today

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO - Vimarsana News

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO

Prioritizing resources to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in workforce executed to align with focus on avexitide; ext...

04.05.23 -- Scaling Cell & Gene Manufacturing, Gene Writing, TCRs in Personalized Oncology and more new episodes out now! - Vimarsana News

04.05.23 -- Scaling Cell & Gene Manufacturing, Gene Writing, TCRs in Personalized Oncology and more new episodes out now!

04/05/23 Life Science Leader Newsletter

Eiger BioPharmaceuticals Announces Leadership Change - Vimarsana News

Eiger BioPharmaceuticals Announces Leadership Change

15.12.2022 - Eiger BioPharmaceuticals, Inc. (“Eiger” or “the company”) (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, and its Board of ... Seite 1

Pittsburgh Sees Transformation into Life Sciences Hotbed - Vimarsana News

Pittsburgh Sees Transformation into Life Sciences Hotbed

A former steel industry giant, the 21st century Pittsburgh is a global life sciences hub, transforming research, technology and startups into a thriving center for innovation.

Pitt and UPMC Enterprises partner to accelerate research commercialization and build Pittsburgh's life sciences economy - Vimarsana News

Pitt and UPMC Enterprises partner to accelerate research commercialization and build Pittsburgh's life sciences economy

Pitt investigators studying women’s health, autoimmune disease and rare neurological diseases can get up to $1 million per year for up to two years through a new partnership.

Source: pitt.edu